MAPT and Cognitive impairment: According to SHAP analysis, tau and cystatin C were the most influential features in both models for clinical impairment classification.<h4>Conclusion</h4>Glial biomarkers significantly enhance diagnostic classification of CDR-defined clinical cognitive impairment beyond core CSF biomarkers.